Robert F. Booth
CIK: 0001507567
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Summit Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
35K shares- - Jan 2, 2026SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
7.2K shares at avg. $8.76- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
35K shares- - Jan 2, 2025SMMT
Summit Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
6.9K shares at avg. $9.18-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 7,180 | $8.76 | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | Award(A) Stock Option (right to buy) | 6,855 | $9.18 | - | Direct |
1-4 of 4 transactions
About Booth Robert F.
Booth Robert F. (SEC CIK 0001507567) files insider reports with the SEC as Director of Summit Therapeutics Inc. (SMMT).
Signal8 holds 2 ownership filings by Booth Robert F., all Form 4s, filed between Jan 6, 2025 and Jan 6, 2026. Those filings report 4 transactions, from Jan 2, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Booth Robert F.'s filings is in MIAMI, FL.
Recent filings by Booth Robert F.
Other insiders filing for Summit Therapeutics Inc. (SMMT)
- Anand Bhaskar, Chief Accounting Officer
- Zanganeh Mahkam, Co-Chief Executive Officer
- DUGGAN ROBERT W, Co-Chief Executive Officer
- Soni Manmeet Singh, COO and CFO
- Xia Yu, Director
- Huber Jeff, Director